Biotechnology News

June 7, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA [OSL:DIAG] (OSE:DIAG) today announced that the first patient with MCI (Mild Cognitive Impairment) was examined with [18F] Flutemetamol PET imaging at University of Lund Sweden in the...

June 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today the publication of a new study characterizing two protein antigens that may hold utility in the design of novel vaccines for Chlamydia trachomatis. The research, led by...

June 7, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced the recipients of its latest Thought Leader award: Dr. Jens Frisvad and the Center for Microbial Biotechnology in the Department of Systems Biology at the...

June 7, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic shareholders voted in favor of all proposals identified in the Proxy Statement at the Company's annual meeting of stockholders.

June 7, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of the novel Biopump™ technology for the sustained production and delivery of therapeutic proteins in patients using their...

June 7, 2012

EXTON, Pa.--(BUSINESS WIRE)--The majority of physicians surveyed by BioTrends report high satisfaction ratings for their patients' responses to their current UAL therapies

June 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KaloBios Pharmaceuticals, Inc. today announced the appointment of Néstor A. Molfino, M.D. as Chief Medical Officer.

June 7, 2012

EXTON, Pa.--(BUSINESS WIRE)--More than three quarters of switches to Gilenya in recently treated patients in the third quarter of 2011 came from patients who had previously taken an interferon-beta or Teva’s Copaxone.

June 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme is participating at the Structure-Based Drug Design Conference, CEO Biotech Conference, the Koch Institute for Integrative Cancer Research's Summer Symposium and BIO International Convention.

June 7, 2012

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--CRI Lifetree presented two research posters at the 52nd Annual NCDEU Meeting.

June 7, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics will host a symposium on galectin science and therapeutic applications September 17-19, 2012, in Boston, MA.

June 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of...

June 7, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--The NCI presented mantle cell lymphoma study results at ASCO showing that vaccination with BiovaxID active immunotherapy resulted in significant overall survival and time-to-next treatment benefits...

June 7, 2012

MIAMI--(BUSINESS WIRE)--David Barshis named CEO of Vigilant Biosciences, developing "rinse and spit" test for oral cancer.

June 7, 2012

SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals, a global, specialty biopharmaceuticals company, has donated $10 million to support research at the Salk Institute for Biological Studies in La Jolla, California.

June 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer creates new Center of Excellence for personalized health.

June 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has completed enrollment in its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the...

June 7, 2012

HAZELWOOD, Mo.--(BUSINESS WIRE)--Mallinckrodt LLC, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it has entered into a co-promotion agreement with Zogenix Inc. (NASDAQ: ZGNX) for SUMAVEL® DosePro® (sumatriptan...

June 7, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today announced the appointment of Charles F. Wagner, Jr. as its Executive Vice President (EVP) and new Chief Financial Officer (CFO), effective on or about June 30, 2012....

June 7, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis completes enrollment for mid dose cohort of CIN study

June 7, 2012

BOSTON--(BUSINESS WIRE)--Expect Miracles Foundation – Financial Services Against Cancer, has been named to Massachusetts General Hospital Cancer Center’s the one hundred list in recognition of its outstanding contributions to the war on cancer....

June 7, 2012

LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant...

June 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with the Allenex group company AbSorber. The project is a pilot study...

June 7, 2012

CHALFONT ST GILES, England, & SOLNA, Sweden--(BUSINESS WIRE)--GE Healthcare (NYSE:GE) signed an agreement with Affibody AB (“Affibody”) to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin...

June 7, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care solutions, will launch the Covidien Nellcor™ Bedside SpO2 Patient Monitoring System at...

June 6, 2012

TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced clinical trial results on the safety and efficacy of delamanid, the company's investigational compound for the treatment of multidrug-resistant tuberculosis (MDR-TB...

June 6, 2012

RICHMOND, Va.--(BUSINESS WIRE)--AIBioTech LLC., a Contract Research Organization providing life science services to government, biotech, and pharmaceutical industry, announced today the hiring of Scott Decker, Ph.D. as the Director of Security....

June 6, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Port Washington, NY (June 6, 2012) -- Pall Corporation (NYSE:PLL) today reported financial results for the third quarter of fiscal year 2012 which ended on April 30, 2012.

June 6, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 32nd Annual William Blair & Company Growth Stock Conference in Chicago. Robin Washington,...

June 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Regenerative medicine company Histogenics Corporation, announced today publication in the Journal of Bone and Joint Surgery (JBJS) of two year results from a Phase 2 randomized clinical trial of the Company’s lead...

June 6, 2012

PARIS--(BUSINESS WIRE)--Breakthrough technologies & strategies in individualized cancer therapy will be disclosed at Win 2012 Symposium on June 28-29 in Paris. Scientific Program ise endorsed by ASCO and credited with CME

June 6, 2012

ZURICH & LUGANO, Switzerland--(BUSINESS WIRE)--EBD Group, the leading partnering firm for the life science industry, will hold the first annual Partnering for Global Impact® July 9–10, 2012 in Lugano, Switzerland.

June 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, has moved its offices to 97 Winthrop Street, in Harvard Square, Cambridge, Massachusetts.

June 6, 2012

WASHINGTON & NEW YORK--(BUSINESS WIRE)--The 4th Annual Scientific American Worldview Report and Scorecard - the most comprehensive country-by-country analysis of biotechnology - reveals the parameters essential for building a successful...

June 6, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced a series of milestones related to the development of ABRAXANE (paclitaxel protein-bound particles for injectable...

June 6, 2012

SCHAUMBURG, Ill.--(BUSINESS WIRE)--The Gateway for Cancer Research’s annual member celebration thanked donors for support and shared promising research. The highlight was Dr. Edward Lin and Thomas Oberdorf, a patient who benefitted.

June 6, 2012

HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today they have accomplished a $1 million dollar raise, part of which completes the Qualifying Financial Transaction milestone for the State of Texas Emerging Technology Fund (ETF)....

June 6, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ), will hold a conference call to discuss fiscal 2012 third quarter results on Tuesday, June 12, 2012, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

June 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The new "Pharmaceutical Regulatory Affairs" study from Cutting Edge Information found that 48% of surveyed companies reported that they increased regulatory affairs staffing in the last three years...

June 6, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics is providing an overview of a molecular testing platform for the early detection of lung cancer and its lead genomic test, BronchoGen, at the 2012 BIO International Convention.

June 6, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS.OB), will be presenting at the XIX International AIDS Conference (AIDS 2012, www...

June 6, 2012

SALZBURG, Austria--(BUSINESS WIRE)--Sony DADC BioSciences today announced that they were the winner in the category of Best New Company 2012 by Select Biosciences at the 2nd Annual European Life Science Awards that were held in Hamburg. Select...

June 6, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Dovetail Health is pleased to announce the additions of Diane Gilworth and Dean McCausland to its senior leadership team. As its new Chief Clinical Officer, Diane Gilworth, RN, NP, MPH, will be responsible for...

June 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic...

June 6, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today the appointments of Lord Paul Boateng, LLB, member of the United Kingdom House of Lords, and Hannah Kettler, PhD, senior health program officer and...

June 6, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa® (dabigatran etexilate) in alignment with the US Food...

June 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. has announced that its phase II study of glycerol phenylbutyrate, an investigational drug for the treatment of episodic hepatic encephalopathy (HE), met its primary...